Next-generation treatments for mental disorders.
There has been a steady retreat by the private sector away from developing medications for mental disorders. This retreat comes just as research is identifying new molecular targets, new clinical targets, and new uses of current treatments that may serve as the basis for the next generation of treatments for mental disorders.
National Institute of Mental Health, Bethesda, MD 20892, USA. insel@mail.nih.gov
Thomas R
TR
Insel
D000928:Antidepressive Agents / Q000627:therapeutic use; D055808:Drug Discovery; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D009473:Neuronal Plasticity / Q000187:drug effects; D011570:Psychiatry / Q000379:methods*
D000928:Antidepressive Agents